Heterologous Prime-Boost HIV-1 Vaccination Regimens in Pre-Clinical and Clinical Trials
Scott A. Brown(St. Jude Children's Research Hospital), Julia L. Hurwitz(St. Jude Children's Research Hospital), Timothy Lockey(St. Jude Children's Research Hospital), Sherri L. Surman(St. Jude Children's Research Hospital), Patricia M. Flynn(St. Jude Children's Research Hospital), Pamela Freiden(St. Jude Children's Research Hospital), Bart G. Jones(St. Jude Children's Research Hospital), Robert E. Sealy(St. Jude Children's Research Hospital), Karen S. Slobod(St. Jude Children's Research Hospital), Kristen Branum(St. Jude Children's Research Hospital), Nanna Howlett(St. Jude Children's Research Hospital)
Cited by 45
Related Papers
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2009|3.6k
Maternal Viral Load, Zidovudine Treatment, and the Risk of Transmission of Human Immunodeficiency Virus Type 1 from Mother to Infant
|New England Journal of Medicine|1996|817
MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs
|Nature Medicine|1999|580
Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention
|New England Journal of Medicine|2016|348